Abstract
Reduction/oxidation (redox) reactions play a central role in the regulation of vascular cell functions. Recent studies in this laboratory have identified c-Ha-ras and osteopontin genes as critical molecular targets during oxidant-induced atherogenesis. This review focuses on the deregulation of gene transcription by redox-activated trans-acting factors after benzo(a)pyrene challenge and the modulation of extracellular matrix signaling in vascular smooth muscle cells by allylamine-induced oxidative injury. The induction of atherogenic vascular smooth muscle cell phenotypes by chemical injury exhibits remarkable parallels with those seen in other forms of atherogenesis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 243-265 |
| Number of pages | 23 |
| Journal | Annual review of pharmacology and toxicology |
| Volume | 39 |
| DOIs | |
| State | Published - 1999 |
Keywords
- Atherosclerosis
- Cell signaling
- Extracellular matrix
- Gene regulation
- Oxidative injury
ASJC Scopus subject areas
- Toxicology
- Pharmacology
Fingerprint
Dive into the research topics of 'Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: Implications in chemical atherogenesis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS